Oncology & Cancer

JAK inhibitors associated with aggressive lymphoma

Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.

Cardiology

Increased risk of thrombosis in myeloproliferative neoplasms

(HealthDay)—Patients with myeloproliferative neoplasms (MPNs) have increased risk of arterial thrombosis and venous thrombosis across all age groups and MPN subtypes, according to a study published online Jan. 16 in the ...

Oncology & Cancer

Low complication rates after screening colonoscopy

During colonoscopy screening for bowel cancer and in the four weeks after the procedure, the risk for complications is low. This is the finding of a prospective cohort study conducted in the Saarland region, published in ...

Oncology & Cancer

Subsequent neoplasm risk up for decades in child CA survivors

(HealthDay)—Survivors of childhood cancer are at increased risk for treatment-related subsequent neoplasms (SNs), even after age 40 years, according to a study published online Aug. 10 in the Journal of Clinical Oncology.

page 3 from 5